A Pediatric Trial Using Tranexamic Acid in Thrombocytopenia

NCT03806556 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped Low accrual rate, strategic reasons

Conditions

Pediatric Cancer
Thrombocytopenia
Hemostatic Disorder
Coagulation Defect; Acquired

Interventions

DRUG: Tranexamic Acid
DRUG: Normal saline

Sponsor

Meghan McCormick